drug development through acquisition of late stage pre-clinical or early stage clinical compounds
History:
eXegenics was founded in 1991 as BioPharmaceutics, Inc. The name was changed to Cytoclonal Pharmaceutics, Inc. in 1992 and to eXegenics, Inc. in October 2001.
